论文信息 - Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial - 字舞流文

Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial

Michael L. Wang | J. Shah | M. Wang | Y. Oki | K. Young | Y. Chen | A. Younes | L. Kwak | L. Zhang | L. Fayad | R. Champlin | S. Neelapu | Sheeba K. Thomas | M. Fanale | F. Hagemeister | B. Pro | M. Desai | C. Hosing | S. Thomas | J. Romaguera | N. Fowler | K. Newberry | N. Wagner-Bartak | M. Badillo | J. Shah | M. Bejarano | R. Champlin | Yiming Chen | N. Cheng | Lei Feng | L. Feng | F. Hagemeister | L. Zhang | Madhav Desai | S. Thomas